Man Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $25.6M | Buy |
135,212
+56,935
| +73% | +$9.95M | 0.05% | 404 |
|
|
2025
Q4 | $13.3M | Buy |
78,277
+35,111
| +81% | +$5.38M | 0.02% | 667 |
|
|
2025
Q3 | $5.69M | Buy |
43,166
+28,750
| +199% | +$3.45M | 0.01% | 1023 |
|
|
2025
Q2 | $1.53M | Sell |
14,416
-3,842
| -21% | -$417K | ﹤0.01% | 1504 |
|
|
2025
Q1 | $2.27M | Sell |
18,258
-8,817
| -33% | -$1.15M | 0.01% | 1318 |
|
|
2024
Q4 | $3.33M | Buy |
27,075
+4,890
| +22% | +$576K | 0.01% | 1157 |
|
|
2024
Q3 | $2.47M | Buy |
22,185
+9,729
| +78% | +$1.07M | 0.01% | 1249 |
|
|
2024
Q2 | $1.33M | Sell |
12,456
-87,388
| -88% | -$9.61M | ﹤0.01% | 1465 |
|
|
2024
Q1 | $12M | Sell |
99,844
-25,461
| -20% | -$3.12M | 0.03% | 627 |
|
|
2023
Q4 | $15.4M | Buy |
+125,305
| New | +$15.6M | 0.04% | 489 |
|
|
2023
Q3 | – | Sell |
-33,502
| Closed | -$4.46M | – | 602 |
|
|
2023
Q2 | $4.15M | Buy |
+33,502
| New | +$4.51M | 0.01% | 954 |
|
|
2023
Q1 | – | Sell |
-30,093
| Closed | -$4.45M | – | 1660 |
|
|
2022
Q4 | $4.79M | Buy |
30,093
+28,388
| +1,665% | +$4.16M | 0.02% | 849 |
|
|
2022
Q3 | $226K | Buy |
+1,705
| New | +$259K | ﹤0.01% | 1742 |
|
|
2022
Q1 | – | Sell |
-2,139
| Closed | -$272K | – | 2264 |
|
|
2021
Q4 | $272K | Buy |
+2,139
| New | +$281K | ﹤0.01% | 1715 |
|
|
2021
Q3 | – | Sell |
-11,628
| Closed | -$2.06M | – | 1992 |
|
|
2021
Q2 | $2.06M | Sell |
11,628
-9,886
| -46% | -$1.71M | 0.01% | 1212 |
|
|
2021
Q1 | $3.54M | Sell |
21,514
-6,880
| -24% | -$1.13M | 0.02% | 862 |
|
|
2020
Q4 | $4.69M | Sell |
28,394
-81,700
| -74% | -$12.2M | 0.02% | 846 |
|
|
2020
Q3 | $15.7M | Buy |
110,094
+3,631
| +3% | +$450K | 0.06% | 336 |
|
|
2020
Q2 | $11.7M | Sell |
106,463
-92,771
| -47% | -$10.3M | 0.06% | 309 |
|
|
2020
Q1 | $19.9M | Sell |
199,234
-14,714
| -7% | -$1.9M | 0.13% | 162 |
|
|
2019
Q4 | $31.9M | Buy |
213,948
+66,978
| +46% | +$9.11M | 0.11% | 227 |
|
|
2019
Q3 | $18.8M | Sell |
146,970
-39,106
| -21% | -$5.24M | 0.07% | 335 |
|
|
2019
Q2 | $26.5M | Buy |
186,076
+24,099
| +15% | +$3.24M | 0.1% | 257 |
|
|
2019
Q1 | $23.2M | Buy |
161,977
+106,111
| +190% | +$13.8M | 0.09% | 275 |
|
|
2018
Q4 | $6.93M | Sell |
55,866
-7,092
| -11% | -$1.05M | 0.03% | 605 |
|
|
2018
Q3 | $10.6M | Buy |
62,958
+34,755
| +123% | +$5.98M | 0.04% | 591 |
|
|
2018
Q2 | $4.86M | Buy |
28,203
+12,596
| +81% | +$2.06M | 0.02% | 960 |
|
|
2018
Q1 | $2.36M | Buy |
+15,607
| New | +$2.29M | 0.01% | 1220 |
|
Other funds holding JAZZ
VPM
VCM
EC
Man Group's JAZZ Position: Q1 2026 in Review
Man Group increased its Jazz Pharmaceuticals (JAZZ) stake by 73% in Q1 2026, buying an estimated $9.95M and bringing the position to 135,212 shares worth $25.6M. The position accounts for 0.05% of the portfolio, ranked #404.
Man Group first reported a position in JAZZ in Q1 2018 and has held it in 28 quarters since. The position peaked at $31.9M in Q4 2019. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Man Group held 135,212 shares of Jazz Pharmaceuticals worth $25.6M as of Q1 2026.
- Man Group bought 56,935 Jazz Pharmaceuticals shares in Q1 2026, an estimated $9.95M.
- Jazz Pharmaceuticals made up 0.05% of Man Group's portfolio in Q1 2026, its #404 holding.
- Man Group first reported a position in Jazz Pharmaceuticals in Q1 2018 and has held it in 28 quarters since.
- Man Group's Jazz Pharmaceuticals position peaked at $31.9M in Q4 2019.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.